Under copyright Constraint(s) on Use: This work is protected by the U.S. Copyright Law (Title 17, U.S.C.). Use of this work beyond that allowed by "fair use" requires written permission of the UC Regents. Responsibility for obtaining permissions and any use and distribution of this work rests exclusively with the user and not the UC San Diego Library. Inquiries can be made to the UC San Diego Library program having custody of the work. Use: This work is available from the UC San Diego Library. This digital copy of the work is intended to support research, teaching, and private study.
Rights Holder and Contact
UC Regents
Description
Dr. Nova holds a Bachelor of Science degree in Biological Sciences from the University of California, Irvine and a Ph.D. in Biochemistry from the University of California, Riverside. From 1994 to January 2000, Dr. Nova served as Chief Operating Officer and President of Nanogen, Inc., a provider of molecular diagnostic tests, where she was a co-founder, and from 1992 to 1994, Dr. Nova served as Chief Operating Officer of Selective Genetics, a targeted therapy biotechnology company. She has served as a member of the board of directors of Arena Pharmaceuticals, Inc. and Cypress Bioscience, Inc., and on the board of trustees of the University of San Diego. Dr. Nova was a life science sector representative to the Independent Citizen’s Oversight Committee overseeing the California Stem Cell Initiative (Proposition 71) from inception through 2008. She served as President and Chief Executive Officer of Genoptix, Inc., and as a member of its Board of Directors. Born digital Special Collections & Archives, UC San Diego, La Jolla, 92093-0175 (https://lib.ucsd.edu/sca) At the time of this interview, Dr. Nova served as President and Chief Operating Officer of Nanogen, Inc. Nova, Tina. Interview conducted by Mark Jones, April 26, 1999. The San Diego Technology Archive (SDTA), UC San Diego Library, La Jolla, CA.
Type
text
Identifier
ark:/20775/bb32451470
Language
English
Subject
Life sciences Creatine kinase Monoclonal antibodies Molecular biology Prostate-specific antigen Women in science Pharmaceutical industry Prizm Pharmaceuticals Nanogen Biopharmaceutical Selective Genetics Hybritech, Inc San Diego (Calif.)
If you're wondering about permissions and what you can do with this item, a good starting point is the "rights information" on this page. See our terms of use for more tips.
Share your story
Has Calisphere helped you advance your research, complete a project, or find something meaningful? We'd love to hear about it; please send us a message.
